Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Faron Pharmaceuticals Oy - Turku, Finland-based clinical-stage biopharmaceutical company - Names Petri Bono as the new chief medical officer with effect from August 15. Bono has served as CMO of Terveystalo, the largest private healthcare service provider in Finland.
Current stock price: 155.00 pence
12-month change: down 40%
Copyright 2024 Alliance News Ltd. All Rights reserved.